Cargando…
Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus responsible for a variety of clinical manifestations that, besides the lungs, can involve several other organs, leading to both mild and severe complications.(1–3)
Autores principales: | Rigamonti, Cristina, Cittone, Micol Giulia, De Benedittis, Carla, Rizzi, Eleonora, Casciaro, Giuseppe Francesco, Bellan, Mattia, Sainaghi, Pier Paolo, Pirisi, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260498/ https://www.ncbi.nlm.nih.gov/pubmed/32480009 http://dx.doi.org/10.1016/j.cgh.2020.05.047 |
Ejemplares similares
-
Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis
por: Bellan, Mattia, et al.
Publicado: (2019) -
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases
por: Bellan, Mattia, et al.
Publicado: (2020) -
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
por: Rizzi, Manuela, et al.
Publicado: (2023) -
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis
por: Lorena, Maria, et al.
Publicado: (2022) -
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
por: Moia, Riccardo, et al.
Publicado: (2021)